MB "Grožio kapsulė" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data

Financial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
113,955 |
113,955 |
13,697 |
13,012 |
13,012 |
62.15 |
11.42 |
16,441 |
85,568 |
70,126 |
31,883 |
2023 |
---|
138,411 |
- |
5,197 |
4,937 |
- |
57.36 |
3.57 |
21,377 |
182,905 |
141,781 |
62,501 |
2024 |
---|
78,705 |
- |
1,576 |
1,497 |
- |
78.62 |
1.90 |
22,755 |
146,858 |
75,283 |
94,330 |
Register and
explore Okredo data2024 |
---|
78,705 |
- |
1,576 |
1,497 |
- |
78.62 |
1.90 |
22,755 |
146,858 |
75,283 |
94,330 |
Register and
explore Okredo data2024
Turnover (€)
78,705 €-43 % *
Sales per employee (€)
-Profit before tax (€)
1,576 €-70 % *
Net Profit (€)
1,497 €-70 % *
Profit per employee (€)
-Total profitability (%)
78.62 %37.06 % *
Net profitability (%)
1.90 %-46.78 % *
Equity (€)
22,755 €6 % *
Amounts Payable And Liabilities (€)
146,858 €-20 % *
Non-current Assets (€)
75,283 €-47 % *
CurrentAssets (€)
94,330 €51 % *